This is a Validated Antibody Database (VAD) review about human Kv4.2, based on 2 published articles (read how Labome selects the articles), using Kv4.2 antibody in all methods. It is aimed to help Labome visitors find the most suited Kv4.2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Kv4.2 synonym: KV4.2; RK5; potassium voltage-gated channel subfamily D member 2; potassium channel, voltage gated Shal related subfamily D, member 2; voltage-gated potassium channel subunit Kv4.2; voltage-sensitive potassium channel

Neuromab
mouse monoclonal (K57/1)
  • western blot; mouse; 1:200; loading ...; fig s2e
In order to use Kcne3 knockout mice to investigate atrial electrophysiology and the development of aldosterone-dependent atrial fibrillation, Neuromab Kv4.2 antibody (Neuro Mab, 75-016) was used in western blot on mouse samples at 1:200 (fig s2e). FASEB J (2016) ncbi
mouse monoclonal (K57/1)
  • immunoprecipitation; rat; loading ...; fig 3a
  • immunocytochemistry; rat; 1:200; loading ...; fig s2
  • immunohistochemistry; rat; 1:500; loading ...; fig s1
  • western blot; rat; 1:1000; loading ...; fig 3a
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1b
Neuromab Kv4.2 antibody (NeuroMab, K57/1) was used in immunoprecipitation on rat samples (fig 3a), in immunocytochemistry on rat samples at 1:200 (fig s2), in immunohistochemistry on rat samples at 1:500 (fig s1), in western blot on rat samples at 1:1000 (fig 3a) and in immunohistochemistry on mouse samples at 1:500 (fig 1b). Neuropharmacology (2016) ncbi
Articles Reviewed
  1. Lisewski U, Koehncke C, Wilck N, Buschmeyer B, Pieske B, Roepke T. Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice. FASEB J. 2016;30:2476-89 pubmed publisher
  2. Gupte R, Kadunganattil S, Shepherd A, Merrill R, Planer W, Bruchas M, et al. Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide. Neuropharmacology. 2016;101:291-308 pubmed publisher